Avalglucosidase alfa
Generic name: avalglucosidase alfa [ AY-val-gloo-KOE-si-dase-AL-fa ]
Brand name: Nexviazyme
Dosage form: intravenous injection (ngpt 100 mg)
Drug class: Lysosomal enzymes
What is avalglucosidase alfa?
Avalglucosidase alfa helps replace an enzyme that is missing in people with a genetic disorder called late-onset Pompe disease, (also called GAA deficiency) in children at least 1 year old.
Avalglucosidase alfa may also be used for purposes not listed in this medication guide.
Avalglucosidase alfa side effects
Get emergency medical help if you have signs of an allergic reaction: hives, itching; difficult breathing; swelling of your face, lips, tongue, or throat.
Some reactions may occur during the injection, or within a few hours afterward. Tell your medical caregiver or get emergency medical help right away if you have:
-
pale skin, blue lips or fingernails;
-
swelling in your tongue;
-
trouble swallowing;
-
dizzines, nausea;
-
rash; or
-
flushing (sudden warmth, redness, or tingly feeling).
Tell your caregivers or get emergency medical help right away if you have any signs of a severe allergic reaction, such as itching, rash, redness or tingling, chest discomfort, wheezing, trouble breathing or swallowing, swelling in your face, pale skin, and blue lips or fingernails.
Common side effects of avalglucosidase alfa may include:
-
headache, dizziness, feeling tired;
-
itching, rash, redness;
-
muscle or joint pain;
-
trouble breathing; or
-
numbness, tingling, burning pain.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Related/similar drugs
Myozyme
Myozyme is used to treat a glycogen storage disorder called Pompe disease. Learn about side ...
Benlysta
Benlysta infusion is used to treat active systemic lupus erythematosus (SLE) and active lupus ...
Lumizyme
Lumizyme (alglucosidase alfa) is used to treat a glycogen storage disorder called Pompe disease ...
Zavesca
Zavesca is used in the treatment of mild to moderate type 1 Gaucher disease. Learn about side ...
Opfolda
Opfolda (miglustat) is an enzyme stabilizer medicine used together with Pombiliti as the new ...
Pombiliti
Pombiliti (cipaglucosidase alfa-agta) is an intravenous infusion that is given over approximately 4 ...
Alglucosidase alfa
Alglucosidase alfa systemic is used for pompe disease
Warnings
Tell your caregivers or get emergency medical help right away if you have any signs of a severe allergic reaction, such as itching, rash, redness or tingling, chest discomfort, wheezing, trouble breathing or swallowing, swelling in your face, pale skin, and blue lips or fingernails.
Before taking this medicine
Tell your doctor if you have ever had:
-
heart disease; or
-
lung disease or breathing problems.
Tell your doctor if you are pregnant or plan to become pregnant. Having untreated Pompe disease during pregnancy may increase your risk of worsened breathing problems and joint or muscle problems. The benefit of treating Pompe disease may outweigh any risks.
Ask a doctor if it is safe to breastfeed while using avalglucosidase alfa.
Your name may be listed on the Pompe Registry. This is to track the progress of your disease and the outcome of your treatment with avalglucosidase alfa.
How is avalglucosidase alfa given?
Avalglucosidase is injected into a vein by a healthcare provider, usually once every 2 weeks.
This medicine must be given slowly over 4 to 5 hours.
You may be given other medications to help prevent serious side effects or allergic reaction. Keep taking these medicines for as long as your doctor has prescribed.
Avalglucosidase alfa dosing information
Usual Adult Dose for Pompe disease:
Less than 30 kg: 40 mg/kg IV every 2 weeks
At least 30 kg: 20 mg/kg every 2 weeks
Comments:
-The patient's actual body weight should be used to calculate the dose.
Use: For the treatment of patients with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency)
Usual Pediatric Dose for Pompe disease:
1 year or older:
-Less than 30 kg: 40 mg/kg IV every 2 weeks
-At least 30 kg: 20 mg/kg every 2 weeks
Comments:
-The patient's actual body weight should be used to calculate the dose.
Use: For the treatment of patients with late-onset Pompe disease (lysosomal GAA deficiency)
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment for your avalglucosidase alfa injection.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while receiving avalglucosidase alfa?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
What other drugs will affect avalglucosidase alfa?
Other drugs may affect avalglucosidase, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.
Avalglucosidase alfa Biosimilars
Biosimilar and interchangeable products are biological products that are highly similar to and have no clinically meaningful differences from the reference product.
Reference products
These are biological products that have already been approved by the FDA, against which biosimilar products are compared. There is 1 for avalglucosidase alfa.
Nexviazyme (avalglucosidase alfa-ngpt) - Genzyme Corporation
Formulation type | Strength |
---|---|
Single-Dose Vial | 100 mg |
View Nexviazyme information in detail.
More about avalglucosidase alfa
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: lysosomal enzymes
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2025 Cerner Multum, Inc. Version: 1.01.